Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arvinas (ARVN) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Arvinas (ARVN) over the last 9 years, with Q3 2025 value amounting to $844.3 million.

  • Arvinas' Liabilities and Shareholders Equity fell 2765.83% to $844.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 2251.86%. This contributed to the annual value of $1.1 billion for FY2024, which is 1634.22% down from last year.
  • Arvinas' Liabilities and Shareholders Equity amounted to $844.3 million in Q3 2025, which was down 2765.83% from $909.3 million recorded in Q2 2025.
  • Arvinas' 5-year Liabilities and Shareholders Equity high stood at $1.6 billion for Q3 2021, and its period low was $644.0 million during Q2 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $1.2 billion, with a median of $1.2 billion in 2023.
  • Per our database at Business Quant, Arvinas' Liabilities and Shareholders Equity soared by 49013.8% in 2021 and then tumbled by 2893.87% in 2025.
  • Over the past 5 years, Arvinas' Liabilities and Shareholders Equity (Quarter) stood at $1.6 billion in 2021, then dropped by 19.78% to $1.3 billion in 2022, then rose by 2.82% to $1.3 billion in 2023, then decreased by 16.34% to $1.1 billion in 2024, then fell by 22.64% to $844.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $844.3 million for Q3 2025, versus $909.3 million for Q2 2025 and $1.0 billion for Q1 2025.